SCMP Hong KongAI 繁中編譯11/11 13:02 (HKT)
李嘉誠資助亞洲首個無創腎腫瘤治療臨床試驗在港進行

香港將成為亞洲首個為腎腫瘤無創治療進行臨床試驗的城市,富商李嘉誠資助三間私家醫院合共30名患者的名額。李嘉誠基金會周三宣布,香港中文大學醫院、港怡醫院……
由 AI 自動翻譯自英文原文(保留香港新聞術語規範)
英文原標題:Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong
英文原摘要:Hong Kong will become the first city in Asia to conduct clinical trials of a non-invasive treatment for kidney tumours, with tycoon Li Ka-shing funding places for 30 patients across three private hospitals. The Li Ka Shing Foundation announced on Wednesday that CUHK Medical Centre, Gleneagles Hospit